EP0537524A1
(de)
*
|
1991-10-17 |
1993-04-21 |
Shipley Company Inc. |
Strahlungsempfindliche Zusammensetzungen und Verfahren
|
GB9316895D0
(en)
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
US20010041786A1
(en)
*
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
WO1997038010A2
(en)
*
|
1996-04-11 |
1997-10-16 |
The University Of British Columbia |
Fusogenic liposomes
|
US5948751A
(en)
*
|
1996-06-20 |
1999-09-07 |
Novo Nordisk A/S |
X14-mannitol
|
US5905140A
(en)
*
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
WO1998002460A1
(en)
*
|
1996-07-11 |
1998-01-22 |
Novo Nordisk A/S |
Selective acylation method
|
ATE417622T1
(de)
|
1996-08-08 |
2009-01-15 |
Amylin Pharmaceuticals Inc |
Regulation gastrointestinaler beweglichkeit
|
UA65549C2
(uk)
*
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
IL134901A0
(en)
*
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
US6933272B1
(en)
|
1998-09-22 |
2005-08-23 |
Erik Helmerhorst |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
US6159931A
(en)
*
|
1998-09-29 |
2000-12-12 |
The Ohio State University |
Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
|
US7181349B1
(en)
|
1999-05-27 |
2007-02-20 |
Cecil Yip |
Identification of compounds for modulating dimeric receptors
|
US6309633B1
(en)
*
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
IL149085A0
(en)
*
|
1999-10-29 |
2002-11-10 |
Inhale Therapeutic Syst |
A dry powder composition containing a di or tripeptide
|
WO2002051428A1
(fr)
*
|
2000-12-25 |
2002-07-04 |
Shiseido Company, Ltd. |
Composition de parfum stimulant le systeme sympathique
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US7905230B2
(en)
*
|
2001-05-09 |
2011-03-15 |
Novartis Ag |
Metered dose inhaler with lockout
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
TW553752B
(en)
*
|
2001-06-20 |
2003-09-21 |
Inhale Therapeutic Syst |
Powder aerosolization apparatus and method
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
SI1436012T1
(en)
*
|
2001-10-18 |
2018-03-30 |
Nektar Therapeutics |
Polymer conjugates of opioid antagonists
|
JP4739672B2
(ja)
*
|
2001-12-21 |
2011-08-03 |
ネクター セラピューティクス |
湿気のバリアを有するカプセルパッケージ
|
US20050051453A1
(en)
*
|
2001-12-21 |
2005-03-10 |
Inhale Therapeutic Systems, Inc. |
Sealing a pharmaceutical formulation in a package
|
AU2003236201A1
(en)
*
|
2002-05-07 |
2003-11-11 |
Novo Nordisk A/S |
Soluble formulations comprising monomeric insulin and acylated insulin
|
US6941980B2
(en)
*
|
2002-06-27 |
2005-09-13 |
Nektar Therapeutics |
Apparatus and method for filling a receptacle with powder
|
JP4654033B2
(ja)
*
|
2002-10-23 |
2011-03-16 |
バークシス コーポレーション |
効率的なプレ−トランス−スプライシング分子の同定のためのスクリーニング方法
|
US7516741B2
(en)
*
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
US20040206350A1
(en)
*
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
AU2003302329B2
(en)
*
|
2002-12-30 |
2010-01-07 |
Novartis Ag |
Prefilming atomizer
|
US20050236296A1
(en)
*
|
2002-12-30 |
2005-10-27 |
Nektar Therapeutics (Formerly Inhale Therapeutic Systems, Inc.) |
Carry case for aerosolization apparatus
|
US7669596B2
(en)
*
|
2002-12-31 |
2010-03-02 |
Novartis Pharma Ag |
Aerosolization apparatus with rotating capsule
|
JP4975966B2
(ja)
|
2002-12-31 |
2012-07-11 |
ネクター セラピューティクス |
ケトンまたは関連する官能基を含むポリマー試薬
|
US8869794B1
(en)
|
2003-04-09 |
2014-10-28 |
Novartis Pharma Ag |
Aerosolization apparatus with capsule puncturing member
|
PL1615689T3
(pl)
|
2003-04-09 |
2016-06-30 |
Novartis Ag |
Urządzenie do aerozolizacji z prowadnicą wyrównującą do przebijania kapsułki
|
ES2383367T5
(es)
*
|
2003-04-09 |
2021-03-31 |
Novartis Ag |
Aparato de pulverización en forma de aerosol con protección de entrada de aire
|
EA011351B1
(ru)
|
2003-05-23 |
2009-02-27 |
Нектар Терапеутикс Ал, Корпорейшн |
Полимерные реагенты, способы их получения, а также содержащие их конъюгаты и фармацевтические препараты
|
WO2005012346A1
(en)
*
|
2003-07-25 |
2005-02-10 |
Conjuchem, Inc. |
Long lasting insulin derivatives and methods thereof
|
KR101200729B1
(ko)
|
2003-09-17 |
2012-11-13 |
넥타르 테라퓨틱스 |
다분지형 고분자 전구약물
|
US20050214224A1
(en)
*
|
2003-11-04 |
2005-09-29 |
Nektar Therapeutics |
Lipid formulations for spontaneous drug encapsulation
|
US20050214250A1
(en)
|
2003-11-06 |
2005-09-29 |
Harris J M |
Method of preparing carboxylic acid functionalized polymers
|
JP2007532096A
(ja)
*
|
2003-11-14 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
アシル化されたインスリンの製造方法
|
WO2005056636A2
(en)
|
2003-12-03 |
2005-06-23 |
Nektar Therapeutics Al, Corporation |
Method of preparing maleimide functionalized polymers
|
EP1694363B1
(de)
|
2003-12-16 |
2014-01-22 |
Nektar Therapeutics |
Monodisperse PEGylierte Naloxol-enthaltende Zusammensetzungen
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
EP1701714A2
(de)
*
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Verbesserte zusammensetzungen mit verzögerter freisetzung für die pulmonale verabreichung von insulin
|
US8562965B2
(en)
|
2004-05-03 |
2013-10-22 |
Nektar Therapeutics |
Polymer derivatives comprising an acetal or ketal branching point
|
US9085659B2
(en)
*
|
2004-05-03 |
2015-07-21 |
Nektar Therapeutics |
Polymer derivatives comprising an imide branching point
|
CN101005857A
(zh)
|
2004-07-08 |
2007-07-25 |
诺和诺德公司 |
多肽延长标记
|
RU2393168C2
(ru)
|
2004-07-19 |
2010-06-27 |
Биокон Лимитед |
Инсулин-олигомерные конъюгаты, их препараты и применения
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
KR20070085227A
(ko)
*
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
WO2006082205A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
CN101184522B
(zh)
*
|
2005-05-18 |
2011-12-21 |
尼克塔治疗公司 |
用于支气管内治疗的阀、设备和方法
|
JP5600240B2
(ja)
|
2005-07-19 |
2014-10-01 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
重合体マレイミド類を調製する方法
|
MX2008001328A
(es)
*
|
2005-07-29 |
2008-04-09 |
Nektar Therapeutics Al Corp |
Metodos para preparar esteres de carbonato de poli (etilenglicol).
|
JP5366546B2
(ja)
|
2005-08-16 |
2013-12-11 |
ノボ・ノルデイスク・エー/エス |
成熟インスリンポリペプチドの作製方法
|
CN101287446A
(zh)
|
2005-09-29 |
2008-10-15 |
尼克塔治疗公司 |
抗生素制剂、单位剂量、试剂盒以及方法
|
WO2007041090A2
(en)
*
|
2005-09-29 |
2007-04-12 |
Nektar Therapeutics |
Receptacles and kits, such as for dry powder packaging
|
CN101389650B
(zh)
|
2005-12-28 |
2012-10-10 |
诺沃-诺迪斯克有限公司 |
包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
|
EP1984009B1
(de)
|
2006-01-18 |
2012-10-24 |
Qps, Llc |
Pharmazeutische zusammensetzungen mit verbesserter stabilität
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
US8933021B2
(en)
*
|
2006-05-09 |
2015-01-13 |
Novo Nordisk A/S |
Insulin derivative
|
DK2054073T3
(da)
*
|
2006-07-11 |
2015-03-02 |
Foresee Pharmaceuticals Inc |
Farmaceutiske præparater til fremføring med langvarig frigivelse af peptider
|
ES2542146T3
(es)
*
|
2006-07-31 |
2015-07-31 |
Novo Nordisk A/S |
Insulinas extendidas PEGiladas.
|
WO2008034881A1
(en)
|
2006-09-22 |
2008-03-27 |
Novo Nordisk A/S |
Protease resistant insulin analogues
|
ES2464282T3
(es)
|
2006-09-27 |
2014-06-02 |
Novo Nordisk A/S |
Método para preparar polipéptidos de insulina madura
|
NZ576637A
(en)
|
2006-10-25 |
2012-05-25 |
Novartis Ag |
Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
|
ES2538082T3
(es)
|
2007-02-11 |
2015-06-17 |
Map Pharmaceuticals Inc |
Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
ES2563038T3
(es)
|
2007-04-30 |
2016-03-10 |
Novo Nordisk A/S |
Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
|
EP2164458A1
(de)
*
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Stabile nichtwässrige pharmazeutische zusammensetzungen
|
WO2008152106A1
(en)
|
2007-06-13 |
2008-12-18 |
Novo Nordisk A/S |
Pharmaceutical formulation comprising an insulin derivative
|
KR20100053561A
(ko)
|
2007-08-15 |
2010-05-20 |
노보 노르디스크 에이/에스 |
아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
|
KR101234540B1
(ko)
|
2007-10-16 |
2013-02-19 |
바이오콘 리미티드 |
경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
|
AU2008317307A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Novartis Ag |
Powder conditioning of unit dose drug packages
|
US9260502B2
(en)
|
2008-03-14 |
2016-02-16 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
US8691759B2
(en)
|
2008-03-18 |
2014-04-08 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
DK2285439T3
(en)
|
2008-04-04 |
2014-03-24 |
Nektar Therapeutics |
Aerosoliseringsanorning
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
WO2010014258A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Nektar Therapeutics Al, Corporation |
Conjugates having a releasable linkage
|
EP2331140B1
(de)
|
2008-08-11 |
2018-07-04 |
Nektar Therapeutics |
Mehrarmige polymer-alkanoat-konjugate
|
US8354435B2
(en)
|
2008-09-08 |
2013-01-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
EP2331139B1
(de)
|
2008-09-11 |
2019-04-17 |
Nektar Therapeutics |
Polymer-alpha-hydroxy-aldehyd und keton-reagenzien und konjugationsverfahren
|
AU2009292643B2
(en)
*
|
2008-09-19 |
2016-02-18 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
WO2010062308A1
(en)
|
2008-10-28 |
2010-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
CA2738615A1
(en)
*
|
2008-10-30 |
2010-05-06 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
SG173117A1
(en)
|
2009-01-28 |
2011-08-29 |
Smartcells Inc |
Crystalline insulin-conjugates
|
WO2010088286A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
WO2010088268A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Exogenously triggered controlled release materials and uses thereof
|
KR101635689B1
(ko)
|
2009-01-28 |
2016-07-01 |
스마트쎌스, 인크. |
제어 약물 전달을 위한 접합체 기재 시스템
|
JP2012517459A
(ja)
|
2009-02-12 |
2012-08-02 |
プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ |
代謝障害治療のためのカルジオトロフィン1の使用
|
WO2010107964A1
(en)
|
2009-03-18 |
2010-09-23 |
Pleiades Cardio-Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
AU2010226243A1
(en)
|
2009-03-20 |
2011-09-22 |
Smartcells, Inc. |
Terminally-functionalized conjugates and uses thereof
|
WO2010107520A1
(en)
|
2009-03-20 |
2010-09-23 |
Smartcells, Inc. |
Soluble non-depot insulin conjugates and uses thereof
|
CN102573967B
(zh)
|
2009-07-17 |
2014-06-11 |
内克塔医疗公司 |
负偏压密封的喷雾器系统和方法
|
BR112012012945A2
(pt)
|
2009-11-25 |
2020-12-29 |
Arisgen Sa |
Composição de liberação mucosal, seu método de produção, complexo de peptídeo pré-formado, kit e uso de um agente ativo de peptídeo
|
EA024879B1
(ru)
|
2010-01-19 |
2016-10-31 |
Нектер Терепьютикс |
Идентификация сухих элементов распылителя
|
JP2013535467A
(ja)
|
2010-07-28 |
2013-09-12 |
スマートセルズ・インコーポレイテツド |
組換えにより発現されたインスリンポリペプチドおよびその使用
|
JP2013541500A
(ja)
|
2010-07-28 |
2013-11-14 |
スマートセルズ・インコーポレイテツド |
組換えレクチン、結合部位修飾レクチンおよびそれらの用途
|
US8933207B2
(en)
|
2010-07-28 |
2015-01-13 |
Smartcells, Inc. |
Drug-ligand conjugates, synthesis thereof, and intermediates thereto
|
BR112013010345A2
(pt)
|
2010-10-27 |
2017-07-25 |
Novo Nordisk As |
tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US20140088021A1
(en)
|
2011-05-27 |
2014-03-27 |
Nektar Therapeutics |
Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
|
KR20140103939A
(ko)
|
2011-12-16 |
2014-08-27 |
노파르티스 아게 |
흡입 프로파일-비의존적 약물 전달을 위한 에어로졸화 장치
|
AU2013247047A1
(en)
|
2012-04-11 |
2014-10-23 |
Novo Nordisk A/S |
Insulin formulations
|
BR112014025737A2
(pt)
|
2012-04-16 |
2017-07-04 |
Cantab Biopharmaceuticals Patents Ltd |
método para administrar um agente terapêutico, método para prevenir a entrada de um agente terapêutico, método para modular a velocidade de liberação de um agente terapêutico, agente terapêutico, formas de dosagem, método de tratamento de uma doença e kit de partes
|
CA2890048C
(en)
|
2012-12-03 |
2022-05-03 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
WO2014177623A1
(en)
|
2013-04-30 |
2014-11-06 |
Novo Nordisk A/S |
Novel administration regime
|
US9884125B2
(en)
|
2013-10-04 |
2018-02-06 |
Merck Sharp & Dohme Corp. |
Glucose-responsive insulin conjugates
|
BR112016007166A2
(pt)
|
2013-10-07 |
2017-09-12 |
Novo Nordisk As |
derivado de um análogo de insulina
|
AR099569A1
(es)
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
WO2015196174A1
(en)
|
2014-06-20 |
2015-12-23 |
Greene Howard E |
Infusion delivery devices and methods
|
WO2017127420A1
(en)
|
2016-01-19 |
2017-07-27 |
Nektar Therapeutics |
Sealed liquid reservoir for a nebulizer
|
CN114847965A
(zh)
|
2016-02-01 |
2022-08-05 |
英凯达治疗公司 |
电子监测联合吸入药理学疗法管理心律失常
|
PE20191205A1
(es)
|
2016-12-16 |
2019-09-10 |
Novo Nordisk As |
Composiciones farmaceuticas que contienen insulina
|
JP2020519628A
(ja)
|
2017-05-10 |
2020-07-02 |
インカーダ セラピューティクス, インコーポレイテッド |
肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法
|
MA49896A
(fr)
|
2017-08-17 |
2020-06-24 |
Novo Nordisk As |
Nouveaux analogues d'insuline acylés et leurs utilisations
|
EP3727424A4
(de)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Konjugatbasierte systeme für kontrollierte insulinfreisetzung
|
WO2019125879A2
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
US10744087B2
(en)
|
2018-03-22 |
2020-08-18 |
Incarda Therapeutics, Inc. |
Method to slow ventricular rate
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
CN114206322A
(zh)
|
2019-06-10 |
2022-03-18 |
瑞必治公司 |
载体基制剂及相关方法
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
CN115843257A
(zh)
|
2020-03-31 |
2023-03-24 |
原聚体科技公司 |
用于对邻位二醇的选择性响应性的缀合物
|
BR112022022885A2
(pt)
*
|
2020-05-15 |
2022-12-20 |
Lilly Co Eli |
Compostos de insulina acilada de ação prolongada
|
PE20231948A1
(es)
|
2020-11-19 |
2023-12-05 |
Protomer Tech Inc |
Compuestos aromaticos que contienen boro y analogos de insulina
|
US20230374045A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|